Susquehanna International Group
REVBW icon

Susquehanna International Group’s Revelation Biosciences Warrant REVBW Stock Holding History

Susquehanna International Group’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262 Buy
+42,266
New +$440 ﹤0.01% 13270
2025
Q3 		– Sell
-33,468
Closed -$402 – 13661
2025
Q2 		$402 Buy
+33,468
New +$405 ﹤0.01% 12528
2024
Q3 		– Sell
-14,575
Closed -$292 – 12862
2024
Q2 		$292 Buy
+14,575
New +$238 ﹤0.01% 11893
2022
Q3 		– Sell
-14,418
Closed -$1K – 13965
2022
Q2 		$1K Buy
+14,418
New +$1.21K ﹤0.01% 12726
2021
Q4 		– Sell
-19,236
Closed -$12K – 13771
2021
Q3 		$12K Buy
19,236
+7,972
+71% +$4.83K ﹤0.01% 12595
2021
Q2 		$7K Buy
+11,264
New +$6.71K ﹤0.01% 12452

Other funds holding REVBW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group's REVBW Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Revelation Biosciences Warrant (REVBW) in Q2 2026: 42,266 shares worth $262. The stake represents ﹤0.01% of the portfolio and ranks #13270 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in REVBW as recently as Q2 2025.

Susquehanna International Group first reported a position in REVBW in Q2 2021 and has held it in 6 quarters since. The position peaked at $12K in Q3 2021. 13 funds tracked by Wall St. Rank hold REVBW as of Q2 2026.

  • Susquehanna International Group held 42,266 shares of Revelation Biosciences Warrant worth $262 as of Q2 2026.
  • Revelation Biosciences Warrant was a new Susquehanna International Group position in Q2 2026.
  • Revelation Biosciences Warrant made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13270 holding.
  • Susquehanna International Group first reported a position in Revelation Biosciences Warrant in Q2 2021 and has held it in 6 quarters since.
  • Susquehanna International Group's Revelation Biosciences Warrant position peaked at $12K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.